+

WO1997001576A3 - Peptides phenyles, leur procede de preparation et les compositions pharmaceutiques qui en renferment - Google Patents

Peptides phenyles, leur procede de preparation et les compositions pharmaceutiques qui en renferment Download PDF

Info

Publication number
WO1997001576A3
WO1997001576A3 PCT/FR1996/001008 FR9601008W WO9701576A3 WO 1997001576 A3 WO1997001576 A3 WO 1997001576A3 FR 9601008 W FR9601008 W FR 9601008W WO 9701576 A3 WO9701576 A3 WO 9701576A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptides
phenyl
amino
pharmaceutical compositions
compositions containing
Prior art date
Application number
PCT/FR1996/001008
Other languages
English (en)
Other versions
WO1997001576A2 (fr
Inventor
Valerie Niddam
Michel Camplo
Jean-Louis Kraus
Original Assignee
Laphal Laboratoires Sa
Valerie Niddam
Michel Camplo
Kraus Jean Louis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BR9606455A priority Critical patent/BR9606455A/pt
Priority to US08/793,647 priority patent/US5844078A/en
Priority to KR1019970701333A priority patent/KR970705576A/ko
Priority to AU64624/96A priority patent/AU706799B2/en
Priority to IL12034196A priority patent/IL120341A/xx
Priority to NZ312726A priority patent/NZ312726A/en
Application filed by Laphal Laboratoires Sa, Valerie Niddam, Michel Camplo, Kraus Jean Louis filed Critical Laphal Laboratoires Sa
Priority to APAP/P/1997/000964A priority patent/AP683A/en
Priority to EP96924035A priority patent/EP0787143A2/fr
Priority to JP9504212A priority patent/JPH10505613A/ja
Publication of WO1997001576A2 publication Critical patent/WO1997001576A2/fr
Priority to NO970895A priority patent/NO970895D0/no
Publication of WO1997001576A3 publication Critical patent/WO1997001576A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention se rapporte au domaine de la chimie organique et plus particulièrement à celui de la chimie thérapeutique. Elle a plus particulièrement pour objet un peptide synthétique contenant au moins neuf amino-acides de formule (I), dans laquelle X et Y sont des résidus d'acides aminés, protégés ou non, ou des peptides; R est un radical alcoyle linéaire ou ramifié; R'' est un radical alcoyle, phényle, halogène, nitro, amino, alcoylamino, alcoxy, trifluorométhyle, trifluorométhoxy, carboxamido ou un cyano; Z est un soufre, un oxygène, un amino ou un sulfoxide et n est égal à 0, 1, 2 ou 3. Les composés de formule (I) sont des inhibiteurs de réplication du HIV en agissant comme inhibiteurs d'une petite aspartyl-protéase dimère qui clive spécifiquement les précurseurs d'une polyprotéine codant pour les protéines de structure et les enzymes constitutives du virus HIV. Utilisation comme médicament.
PCT/FR1996/001008 1995-06-29 1996-06-28 Peptides phenyles, leur procede de preparation et les compositions pharmaceutiques qui en renferment WO1997001576A2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US08/793,647 US5844078A (en) 1995-06-29 1996-06-28 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides
KR1019970701333A KR970705576A (ko) 1995-06-29 1996-06-28 페닐 펩티드, 이를 제조하는 방법, 및 이 펩티드를 함유하는 약제학적 조성물(phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides)
AU64624/96A AU706799B2 (en) 1995-06-29 1996-06-28 Phenyl peptides, method for preparing same and pharmaceutical compositions containing said peptides
IL12034196A IL120341A (en) 1995-06-29 1996-06-28 Phenyl peptides their preparation and pharmaceutical compositions containing them
NZ312726A NZ312726A (en) 1995-06-29 1996-06-28 Phenyl peptides; preparation; medicaments
BR9606455A BR9606455A (pt) 1995-06-29 1996-06-28 Peptídeo sintético processo de obtenção de peptídeos composições farmacêuticas e intermediário
APAP/P/1997/000964A AP683A (en) 1995-06-29 1996-06-28 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides.
EP96924035A EP0787143A2 (fr) 1995-06-29 1996-06-28 Peptides phenyles, leur procede de preparation et les compositions pharmaceutiques qui en renferment
JP9504212A JPH10505613A (ja) 1995-06-29 1996-06-28 フェニルペプチドと、その製造方法と、このペプチドを含む医薬品組成物
NO970895A NO970895D0 (no) 1995-06-29 1997-02-27 Fenylpeptider, fremgangsmåte for fremstilling av disse, og farmasöytiske preparater inneholdende disse peptider

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR95/07817 1995-06-29
FR9507817A FR2736055B1 (fr) 1995-06-29 1995-06-29 Nouveaux thiophenoxy peptides, leur procede de preparation et les compositions pharmaceutiques en renfermant

Publications (2)

Publication Number Publication Date
WO1997001576A2 WO1997001576A2 (fr) 1997-01-16
WO1997001576A3 true WO1997001576A3 (fr) 1997-05-15

Family

ID=9480502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1996/001008 WO1997001576A2 (fr) 1995-06-29 1996-06-28 Peptides phenyles, leur procede de preparation et les compositions pharmaceutiques qui en renferment

Country Status (17)

Country Link
US (1) US5844078A (fr)
EP (1) EP0787143A2 (fr)
JP (1) JPH10505613A (fr)
KR (1) KR970705576A (fr)
CN (1) CN1165521A (fr)
AP (1) AP683A (fr)
AU (1) AU706799B2 (fr)
BR (1) BR9606455A (fr)
CA (1) CA2197861A1 (fr)
FR (1) FR2736055B1 (fr)
HU (1) HUP9701940A3 (fr)
IL (1) IL120341A (fr)
NO (1) NO970895D0 (fr)
NZ (1) NZ312726A (fr)
OA (1) OA10403A (fr)
PL (1) PL318880A1 (fr)
WO (1) WO1997001576A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1292438B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Derivati peptidomimetici inibitori suicidi della proliferazione del hiv
US6118226A (en) 1998-07-31 2000-09-12 Federal-Mogul World Wide, Inc. Electrodeless neon light module for vehicle lighting systems
US8886480B2 (en) 2011-06-27 2014-11-11 Synaptics Incorporated System and method for signaling in gradient sensor devices
US9188675B2 (en) 2012-03-23 2015-11-17 Synaptics Incorporated System and method for sensing multiple input objects with gradient sensor devices

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094815A2 (fr) * 1982-05-18 1983-11-23 Smithkline Beckman Corporation Oligopeptides prémédicamenteux
US4454065A (en) * 1982-05-18 1984-06-12 Smithkline Beckman Corporation Oligopeptide prodrugs
EP0331921A1 (fr) * 1988-02-11 1989-09-13 Warner-Lambert Company Inhibiteurs de la rénine, contenant des alpha-hétéroatome-acides aminés
WO1991010679A2 (fr) * 1990-01-22 1991-07-25 Warner Lambert Co PEPTIDES INHIBANT LA RENINE, PRESENTANT UN ACIDE AMINE A 'alpha'-HETEROATOMES EN POSITION P3

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1193598A (fr) * 1982-05-06 1985-09-17 Rafael Foguet Derives d'acide 2-amino-benzoique et methode de preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094815A2 (fr) * 1982-05-18 1983-11-23 Smithkline Beckman Corporation Oligopeptides prémédicamenteux
US4454065A (en) * 1982-05-18 1984-06-12 Smithkline Beckman Corporation Oligopeptide prodrugs
EP0331921A1 (fr) * 1988-02-11 1989-09-13 Warner-Lambert Company Inhibiteurs de la rénine, contenant des alpha-hétéroatome-acides aminés
WO1991010679A2 (fr) * 1990-01-22 1991-07-25 Warner Lambert Co PEPTIDES INHIBANT LA RENINE, PRESENTANT UN ACIDE AMINE A 'alpha'-HETEROATOMES EN POSITION P3

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KINGSBURY, WILLIAM D. ET AL: "Synthesis of.alpha.-thiophenylglycine peptides. Novel peptide substrates useful in the study of microbial peptide transport", INT. J. PEPT. PROTEIN RES. (1986), 27(6), 659-65 CODEN: IJPPC3;ISSN: 0367-8377, XP000565713 *
KRAUS, J. L. ET AL: "Synthesis and biological activities of new N-formylated methionyl peptides containing an.alpha.-substituted glycine residue", EUR. J. MED. CHEM. (1992), 27(1), 19-26 CODEN: EJMCA5;ISSN: 0223-5234, XP000647634 *
REPINE, JOSEPH T. ET AL: "Renin inhibitors containing.alpha.-heteroatom amino acids as P2 residues", J. MED. CHEM. (1992), 35(6), 1032-42 CODEN: JMCMAR;ISSN: 0022-2623, XP002027957 *
V. NIDDAM ET AL.: "Thiophenoxy Peptides: A New Class of HIV Replication Inhibitors", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 6, no. 6, 1996, pages 609 - 614, XP000647604 *

Also Published As

Publication number Publication date
FR2736055B1 (fr) 1997-09-12
BR9606455A (pt) 1998-07-14
NO970895L (no) 1997-02-27
AP683A (en) 1998-09-30
CN1165521A (zh) 1997-11-19
EP0787143A2 (fr) 1997-08-06
AU6462496A (en) 1997-01-30
IL120341A0 (en) 1997-06-10
CA2197861A1 (fr) 1997-01-16
WO1997001576A2 (fr) 1997-01-16
HUP9701940A3 (en) 2001-07-30
AU706799B2 (en) 1999-06-24
KR970705576A (ko) 1997-10-09
FR2736055A1 (fr) 1997-01-03
HUP9701940A2 (hu) 1998-03-02
PL318880A1 (en) 1997-07-07
JPH10505613A (ja) 1998-06-02
NO970895D0 (no) 1997-02-27
IL120341A (en) 2001-01-28
AP9700964A0 (en) 1997-04-30
NZ312726A (en) 1998-07-28
OA10403A (fr) 2001-12-05
US5844078A (en) 1998-12-01

Similar Documents

Publication Publication Date Title
BR9305162A (pt) Composto, formulação farmacêutica e processo para a preparação de um composto
WO2000059506A8 (fr) BIPHENYLES CONTENANT DES HETEROCYCLIQUES INHIBITEURS D'aP2 ET METHODE
EP0756625A1 (fr) Inhibiteurs irreversibles de cysteine-protease contenant des groupes vinyl conjugues avec des groupes attracteurs d'electrons
AR009815A1 (es) Composicion detergente liquida que comprende un surfactante, enzima proteolitica e inhibidor de proteasa de peptido y compuestos de peptidocomprendidos en la misma
DK0810209T3 (da) Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
KR970707069A (ko) 매트릭스 금속프로테아제 억제제로서 치환된 4-비아릴부티르산 또는 5-비아릴펜탄산 및 그의 유도체(substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metallorotease inhibitors)
MY137301A (en) Peptide analogs as irreversible interleukin-1b protease inhibitors
AU5788800A (en) Peptide boronic acid inhibitors of hepatitis c virus protease
EP0387231A3 (fr) Inhibiteurs des protéases rétro-virales
DK0810208T3 (da) N-substituerede hydroxyethylamino sulfaminsyrederivater til anvendelse som inhibitorer af retrovirale proteaser
JPS5754157A (en) L-argininal derivative and its preparation
CA2399486A1 (fr) Utilisation de solutes compatibles pour proteger des biopolymeres macromoleculaires contre une decomposition par des enzymes a pouvoir degradant
DZ2681A1 (fr) Forme nouvelle d'hydrate de sel d'acide maléique de 5-Ä4-Ä2-(n-methyl-n(2-pyridyl)amino)ethoxyÜbenzylÜ-thiazololidine-2,4-dione et composition pharmaceutique la contenant.
WO1997001576A3 (fr) Peptides phenyles, leur procede de preparation et les compositions pharmaceutiques qui en renferment
EP0498784A3 (en) Inhibitors of retroviral protease
IL111660A (en) Oligonucleoside compounds for effecting rnaseh-mediated cleavage of a target ribonucleic acid sequence and a pharmaceutical composition containing them
CA2060573A1 (fr) N-(aryloxyalkyl)heteroaryl-8-azabicyclo¬3.2.1|octanes; produits intermediaires et methode pour leur preparation; utilisation comme medicaments
BR9812389A (pt) Derivado de 1,5 difenilpinazol, processo para prepará-lo e seus usos
ES2045067T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
MX9503070A (es) Sistema de expresion que utiliza proteinas de fusion autolisables y un polipeptido de reduccion novedoso.
CO4950550A1 (es) Procedimiento
WO2003062261A3 (fr) Derives dmt-tic di- et tripeptidiques, compositions connexes et methodes d'utilisation
AU3604093A (en) Use of 5,5'-dithio-bis(2-nitrobenzoic acid) for inhibition of HIV protease
DE69820511D1 (de) Aminosäurederivate und diese enthaltende Zusammensetzungen zur Hemmung von aktivem Sauerstoff
DK0955310T3 (da) Hidtil ukendte (3,4,7,8,9,10)-hexahydro-6,10-dioxo-6H-pyridazino[1,2-a][1,2]diazepin-1-carboxylsyrederivater, fremgangsmåde til fremstilling af disse og anvendelse af disse til fremstilling af lægemidler

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96190943.9

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN CZ HU IL JP KR MX NO NZ PL RO RU SK US VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 312726

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2197861

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1996924035

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 08793647

Country of ref document: US

Ref document number: 1199700148

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: PA/a/1997/001482

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1019970701333

Country of ref document: KR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1996924035

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1019970701333

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1019970701333

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1996924035

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载